David Charles Lubner - 22 May 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
23 May 2025, 17:45:12 UTC
Previous filing
06 Jun 2024
Next filing
30 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lubner David Charles Director C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE /s/ Katie Kazem, Attorney-in-Fact 23 May 2025 0001572000

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 22 May 2025 Common Stock 30,000 $0.1868 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 22, 2026 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.